The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.d

Acute eosinophilic pneumonia (AEP)

Publications

Elbarbry F, Farthing K, Arguello S

Diagnosis and Management of Daptomycin-Induced Acute Eosinophilic Pneumonia: A Case Report.

Innovations in pharmacy 2024;15; — 2024

Hassett MR

Daptomycin-induced eosinophilic pneumonia.

JAAPA : official journal of the American Academy of Physician Assistants 2024 Apr 01;37 — 2024 Apr 01 — 1-4

Pham TT, Garreau R, Craighero F, Cottin V, Said BB, Goutelle S, Ferry T

Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm.

Open forum infectious diseases 2022 Nov;9;ofac577 — 2022 Nov — ofac577

Abd Algayoum R, Elsherif A, Khan ZH, Roman G

Daptomycin-Induced Eosinophilic Pneumonia Mimicking Multifocal Pneumonia.

Cureus 2022 Oct;14;e30521 — 2022 Oct — e30521

Raman V, Chaudhary I, Shieh S

Eosinophilic pneumonia: a case of daptomycin induced lung injury.

Journal of community hospital internal medicine perspectives 2021 Mar 23;11;280-285 — 2021 Mar 23 — 280-285

Storandt MH, Matta A

Acute Eosinophilic Pneumonia: A Rare Complication of Daptomycin Therapy.

Cureus 2020 Jan 28;12;e6803 — 2020 Jan 28 — e6803

Bartal C, Sagy I, Barski L

Drug-induced eosinophilic pneumonia: A review of 196 case reports.

Medicine 2018 Jan;97;e9688 — 2018 Jan — e9688

De Giacomi F, Decker PA, Vassallo R, Ryu JH

Acute Eosinophilic Pneumonia: Correlation of Clinical Characteristics With Underlying Cause.

Chest 2017 08;152;379-385 — 2017 08 — 379-385

Montenegro O, Del Campo R, Del Rio JJ, Ambrós Checa A

[Acute eosinophilic pneumonia secondary to daptomycin].

Enfermedades infecciosas y microbiologia clinica 2016 Jun-Jul;34;390-1 — 2016 Jun-Jul — 390-1

Patel JJ, Antony A, Herrera M, Lipchik RJ

Daptomycin-induced acute eosinophilic pneumonia.

WMJ : official publication of the State Medical Society of Wisconsin 2014 Oct;113;199-201 — 2014 Oct — 199-201

Chiu SY, Faust AC, Dand HM

Daptomycin-induced eosinophilic pneumonia treated with intravenous corticosteroids.

Journal of pharmacy practice 2015 Jun;28;275-9 — 2015 Jun — 275-9

Yusuf E, Perrottet N, Orasch C, Borens O, Trampuz A

Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.

Surgical infections 2014 Dec;15;834-7 — 2014 Dec — 834-7

Phillips J, Cardile AP, Patterson TF, Lewis JS

Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports.

Scandinavian journal of infectious diseases 2013 Oct;45;804-8 — 2013 Oct — 804-8

Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S

Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Drug safety 2012 Jun 01;35;447-57 — 2012 Jun 01 — 447-57

Rether C, Conen A, Grossenbacher M, Albrich WC

A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Infection 2011 Dec;39;583-5 — 2011 Dec — 583-5

Miller BA, Gray A, Leblanc TW, Sexton DJ, Martin AR, Slama TG

Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010 Jun 01;50;e63-8 — 2010 Jun 01 — e63-8